News
Japan health panel recommends allowing import, use of medical marijuana products

TOKYO, Sept 29 (Reuters) – A Japanese health ministry panel on Thursday recommended revising the nation’s drug laws to allow for the importation and use of medicinal marijuana products.
The recommendation was based on meeting medical needs and to harmonise Japan with international standards, the committee said in a report. The revision would apply to marijuana products whose safety and efficacy were confirmed under laws governing pharmaceuticals and medical devices.
Japan has very strict laws banning the importation, production, and use of illicit substances. The committee’s report noted that only 1.4% of people in Japan had ever used marijuana, compared to 20-40% in Western countries.
Revision of the law would be necessary for the use of the cannabis-derived epilepsy drug Epidiolex, which is currently undergoing clinical trials in Japan, the report said.
Reporting by Rocky Swift
Editing by Raissa Kasolowsky
Our Standards: The Thomson Reuters Trust Principles.
Read the full article here
-
Videos1 week ago
NH representatives discuss marijuana legalization bill
-
Politics1 week ago
New Bipartisan Congressional Bills Would Allow Hemp Derivatives Like CBD As Dietary Supplements And Food Additives
-
Videos1 week ago
Marijuana money lost to Illinois
-
Videos1 week ago
Hemp business owners concerned cannabis reform bill could destroy them
-
Videos7 days ago
Two Colorado Springs marijuana dispensaries cited by state authorities for high mold, yeast …
-
Videos1 week ago
Oregon pot prices: Too much weed, not enough demand
-
Videos1 week ago
Medical marijuana bill passes through KY Senate for first time ever
-
Events1 week ago
Announcing the High Times Cannabis Cup New Mexico: People’s Choice Edition 2023